Y-Biologics, Inc (338840) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Y-Biologics, Inc stock KRW 5,418, price KRW 8,010, that is 32.4% below the price, quality 24 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Y-Biologics, Inc
338840 · KQExpensive (fair value 32% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 16, 2026.
How to read this chart
35‑month range 5,480 KRW – 35,600 KRW · fair‑value band 4,063 KRW – 6,772 KRW · the 8,010 KRW price screens above the 5,418 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 16, 2026.
Every Wednesday you see whether Y-Biologics is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Y-Biologics, Inc., an antibody therapeutics development company, engages in the research and development of immuno-oncology drugs and antibody drugs. The company develops YBL-006, a PD-1 immune-oncology agent that is phase 1 clinical stage for the treatment of solid tumor.
Show moreShow less
It also develops immunoregulatory monoclonal antibodies, such as YBL-011 and AR062 for the treatment of solid cancers; AR166, AR169, and AR170 for solid cancers; and AR153, a pH-dependent antibody for the treatment of solid cancer.
Y-Biologics, Inc. was incorporated in 2007 and is headquartered in Daejeon, South Korea.
Stock analysis
Y-Biologics, Inc (338840) currently trades at 8,010 KRW, while our estimate is 5,418 KRW, 32% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 4,063 KRW (bear) to 6,772 KRW (bull), the price of 8,010 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 24/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Y-Biologics, Inc reported revenue of 2.9B KRW in FY2025 versus 4.8B KRW in FY2021, a compound −12.0%/yr. Reported net income was −42.0B KRW in FY2025.
Key figures
Market cap 124B KRW (≈ $92.8M) Micro · P/S ratio 43.8 · EPS (TTM) −3,251 KRW · Return on equity −298% · Return on assets (EBIT) −45.9% (5-year average) · Operating margin −245% · Revenue (TTM) 3.2B KRW · Revenue growth (YoY) +32.9%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).
What moves the price
The share trades about 78% below its 52-week high and 20% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −32%, 338840 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare Y-Biologics, Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 848 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Revenue growth by industry
- PEG ratio by industry
- Stock screener with 62 metrics
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs 338840 |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs 338840 |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs 338840 |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs 338840 |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs 338840 |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs 338840 |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs 338840 |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs 338840 |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs 338840 |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs 338840 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Y-Biologics, Inc (338840) overvalued or undervalued?
What is the fair value of 338840?
What is the quality score of 338840?
What is the price target for Y-Biologics, Inc (338840)?
What is the Y-Biologics, Inc stock forecast for 2026?
What is the revenue of Y-Biologics, Inc (338840)?
What is the intrinsic value of Y-Biologics, Inc (338840)?
Is Y-Biologics, Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 338840?
How much is Y-Biologics, Inc worth?
What do the bullish and bearish scenarios say about 338840?
How solid is the balance sheet of Y-Biologics, Inc (338840)?
How far is 338840 from its 52-week high?
Which stocks are comparable to Y-Biologics, Inc?
Is Y-Biologics, Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of Y-Biologics, Inc (338840)?
What should I pay attention to with Y-Biologics, Inc right now?
Key figures of Y-Biologics, Inc
How large is the market capitalisation of Y-Biologics, Inc (338840)?
What is the P/S ratio of Y-Biologics, Inc (338840)?
What are the earnings per share of Y-Biologics, Inc (338840)?
What is the return on equity of Y-Biologics, Inc (338840)?
What is the EBIT return on assets of Y-Biologics, Inc (338840)?
What is the operating margin of Y-Biologics, Inc (338840)?
How fast is revenue growing at Y-Biologics, Inc (338840)?
How much free cash flow does Y-Biologics, Inc (338840) generate?
Watch Y-Biologics, Inc in the live analysis
One click puts Y-Biologics, Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.